REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPHW)
2025-06-30 | ||||
|---|---|---|---|---|
| Provision for income taxes | 7,954 | |||
| Research and development | 3,724,755 | |||
| General and administrative | 2,348,227 | |||
| Total operating expenses | 6,072,982 | |||
| Loss from operations | -6,072,982 | |||
| Other expense, net | -1,850 | |||
| Interest income | 22,847 | |||
| Interest expense | 4,797 | |||
| Gain on remeasurement of warrant liabilities | 11,126 | |||
| Total other income, net | 27,326 | |||
| Loss before provision for income taxes | -6,045,656 | |||
| Net loss | -6,053,610 | |||
| Basic and diluted (in dollars per share) | -0.12 | |||
| Basic and diluted (in shares) | 49,847,872 | |||